Guillain-Barré syndrome and influenza vaccines: a meta-analysis

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Assessment of risk minimisation measure implementation or effectiveness

Non-interventional study

• Non-interventional study design:
  Systematic review and meta-analysis

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09
• Medical condition to be studied:
  Guillain-Barre syndrome

Population studied

• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  99999999

Study design details

• Main study objective:
  The specific aim of this study was to explore the possible association between influenza vaccines and Guillain-Barré syndrome.
• Data analysis plan:
  Overall risk estimation (RevMan / Cochrane)